Abstract
Thyroid carcinoma arising from normal follicular cells is generally slow-growing with an excellent prognosis if competently resected. However, once the tumor dedifferentiates and becomes undifferentiated (anaplastic) carcinoma, it becomes one of the most aggressive malignancies. Such a polarized characteristic is quite unique yet typical of thyroid carcinoma. To date, many researchers have studied differences in the characteristics of thyroid carcinoma before and after dedifferentiation. In this review, the difference in cell proliferating activity and the expression of cell cycle modulators is addressed. Cell proliferating activity of undifferentiated carcinoma is definitely higher than that of differentiated carcinoma. However, expression of cell cycle modulators in thyroid carcinoma is often unique and even discrepant. Some negative modulators are diffusely expressed and reduced expression of some positive modulators can be observed in undifferentiated carcinoma. We described these interesting findings in thyroid carcinoma in this review.
Keywords: thyroid cancer, cell cycle, cell proliferation
Current Cancer Therapy Reviews
Title: Expression of Cell Cycle Regulators in Thyroid Neoplasms Originating from Follicular Cells
Volume: 1 Issue: 2
Author(s): Yasuhiro Ito
Affiliation:
Keywords: thyroid cancer, cell cycle, cell proliferation
Abstract: Thyroid carcinoma arising from normal follicular cells is generally slow-growing with an excellent prognosis if competently resected. However, once the tumor dedifferentiates and becomes undifferentiated (anaplastic) carcinoma, it becomes one of the most aggressive malignancies. Such a polarized characteristic is quite unique yet typical of thyroid carcinoma. To date, many researchers have studied differences in the characteristics of thyroid carcinoma before and after dedifferentiation. In this review, the difference in cell proliferating activity and the expression of cell cycle modulators is addressed. Cell proliferating activity of undifferentiated carcinoma is definitely higher than that of differentiated carcinoma. However, expression of cell cycle modulators in thyroid carcinoma is often unique and even discrepant. Some negative modulators are diffusely expressed and reduced expression of some positive modulators can be observed in undifferentiated carcinoma. We described these interesting findings in thyroid carcinoma in this review.
Export Options
About this article
Cite this article as:
Ito Yasuhiro, Expression of Cell Cycle Regulators in Thyroid Neoplasms Originating from Follicular Cells, Current Cancer Therapy Reviews 2005; 1 (2) . https://dx.doi.org/10.2174/1573394054021736
DOI https://dx.doi.org/10.2174/1573394054021736 |
Print ISSN 1573-3947 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6301 |
Call for Papers in Thematic Issues
Current progress in Protein Degradation and Cancer Therapy
argeted Protein Degradation is gaining momentum in cancer therapy, it facilitate targeting undruggable proteins, it overcome cancer resistance and avoid undesirable side effects. Thus small molecules degraders have emerged as novel therapeutic strategy. Targeted protein degradation (TPD), the process of eliminating a protein of interest hold a great promise for ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Recent Advances in the Synthesis of Biologically Relevant Selenium-containing 5-Membered Heterocycles
Current Organic Chemistry Application of Nanotechnology in Miniaturized Systems and its Use for Advanced Analytics and Diagnostics – an Updated Review
Recent Patents on Food, Nutrition & Agriculture Advances in Exploring the Role of Micrornas in Inflammatory Bowel Disease
MicroRNA Implications of Fibroblast Growth Factors (FGFs) in Cancer: From Prognostic to Therapeutic Applications
Current Drug Targets Nonviral Vectors for Cancer Gene Therapy: Prospects for Integrating Vectors and Combination Therapies
Current Gene Therapy The Interplay between Indoleamine 2,3-Dioxygenase 1 (IDO1) and Cyclooxygenase (COX)-2 In Chronic Inflammation and Cancer
Current Medicinal Chemistry Acute and Long-Term Effects of Cannabis Use: A Review
Current Pharmaceutical Design Potential Therapeutic Application of Chondroitin Sulfate/Dermatan Sulfate
Current Drug Discovery Technologies Glycosite Analysis in Glycoproteomics by Mass Spectrometry
Current Proteomics Muscarinic Acetylcholine Receptor-Interacting Proteins (mAChRIPs): Targeting the Receptorsome
Current Drug Targets Distinctive Phenotype Identification for Breast Cancer Genotypes Among Hereditary Breast Cancer Mutated Genes
Current Bioinformatics An Agathokakological Tale of Δ<sup>9</sup>-THC: Exploration of Possible Biological Targets
Current Drug Targets Bcl-2 Inhibitors: Emerging Drugs in Cancer Therapy
Current Medicinal Chemistry Immune Therapy in Pancreatic Cancer: Now and the Future?
Reviews on Recent Clinical Trials Herbal and Traditional Chinese Medicine for the Treatment of Cardiovascular Complications in Diabetes Mellitus
Current Diabetes Reviews The Importance of TLR3 Expression and Hormonal Regulation of TLR3- Induced Immune Responses in the Human Endometrium
Current Immunology Reviews (Discontinued) Small-Animal Molecular Imaging for Preclinical Cancer Research: μPET and μSPECT
Current Radiopharmaceuticals Biological Denitrification: Screening of Packing Material, Comparison of Denitrification Rate by Pseudomonas aeruginosa and Pseudomonas stutzeri, Application and Design of Bioreactor
Current Environmental Engineering Interactive Effect of Combined Exposure to Active and Passive Smoking on Cardiovascular System
Recent Patents on Cardiovascular Drug Discovery Listeria monocytogenes as a Vector for Anti-Cancer Therapies
Current Gene Therapy